Pain Without Damage: Central Sensitization and the Pathophysiology of Fibromyalgia in a 44-Year-Old Teacher
[Student Name]
University of Phoenix
NSG/521: Advanced Pathophysiology
Week 6 Assignment
[Instructor Name]
[Date]
Composite patient written as a model document. No real patient is described.
A composite 44-year-old elementary school teacher saw her nurse practitioner for pain that had spread over two years from her neck and shoulders to her back, hips and legs. She described it as aching and burning, worse after a day on her feet and during stressful weeks, with a typical daily intensity of 7 on a 10-point scale. She woke unrefreshed after eight hours in bed, felt exhausted by midafternoon and struggled to remember words in front of her class, which she called brain fog. Her examination showed tenderness to light pressure across many sites but no joint swelling, weakness or neurologic deficit. Her blood count, inflammatory markers, thyroid function, vitamin D and creatine kinase were normal. Everything that could be measured in her tissues was normal, yet the pain was real, persistent and disabling; the explanation lies not in her muscles but in how her nervous system processes signals from them. This paper explains the pathophysiology of fibromyalgia through central sensitization.
Normal Pain Processing
In normal nociception, tissue injury activates peripheral nociceptors, which send signals through the dorsal horn of the spinal cord to the brain, where they are perceived as pain. The system is regulated in both directions. Excitatory neurotransmitters such as glutamate and substance P amplify signals in the dorsal horn, while descending pathways from the brainstem, using serotonin, norepinephrine and endogenous opioids, inhibit transmission. Pain normally matches the intensity of the stimulus and fades as tissue heals.
Central Sensitization
Woolf (2011) described central sensitization as an amplification of neural signaling within the central nervous system that produces pain hypersensitivity: the system responds more strongly to input, responds to input that is normally not painful and continues to respond after the input ends. Mechanisms include increased excitability of dorsal horn neurons, driven by glutamate acting on NMDA receptors and by substance P, expansion of receptive fields and reduced effectiveness of descending inhibition. In this state, pain no longer reflects tissue damage; it reflects the gain of the system.
Clauw (2014) described fibromyalgia as the prototypical centralized pain condition. Studies have found increased concentrations of substance P and glutamate in the cerebrospinal fluid of people with fibromyalgia, reduced activity of descending inhibitory systems, altered connectivity in pain-processing regions of the brain seen on functional imaging and increased sensitivity not only to pressure but also to heat, sound and other stimuli. A subset of patients also shows reduced density of small nerve fibers in the skin, which suggests that peripheral contributions may add to the central amplification in some people.
Linking the Mechanism to Her Symptoms
Each of her symptoms reflects the mechanism. Her widespread pain and tenderness to light pressure reflect amplified processing: normal pressure is experienced as painful, a feature called allodynia, and painful stimuli feel more painful, called hyperalgesia. The burning quality reflects abnormal central processing rather than a specific injury. The worsening with stress reflects the influence of stress systems on descending pain modulation.
Her unrefreshing sleep is both a symptom and an amplifier. Sleep disruption reduces pain inhibition, and experimental sleep deprivation in healthy people can produce widespread tenderness, while pain in turn disrupts sleep, forming a cycle. Her fatigue and cognitive difficulties are part of the same centralized state, reflecting altered brain function in networks that also regulate attention and memory.
The Diagnostic Criteria as a Map of the Mechanism
Because no test shows central sensitization directly, diagnosis rests on its clinical expression. The 2016 revision of the American College of Rheumatology criteria requires generalized pain in at least four of five body regions, symptoms present for at least three months and a combination of a widespread pain index and a symptom severity scale score that captures fatigue, unrefreshing sleep and cognitive symptoms (Wolfe et al., 2016). The patient's widespread pain index was 11 of 19 painful areas, and her symptom severity score was 8 of 12, meeting the thresholds. The revision also stated that fibromyalgia can be diagnosed alongside other conditions, since central sensitization can coexist with arthritis, lupus or other diseases.
The normal laboratory tests were still necessary. Hypothyroidism, inflammatory arthritis, polymyalgia rheumatica, myositis and medication effects such as statin myopathy can cause widespread pain and fatigue, and each was excluded by examination and testing.
Who Develops Fibromyalgia
The mechanism also helps explain who is at risk. Fibromyalgia is more common in women and often runs in families, and first-degree relatives of affected people show greater pain sensitivity, suggesting inherited differences in pain modulation. Triggers that can precede onset include physical trauma, infections, surgery and prolonged psychological stress, all of which can push a susceptible nervous system into a sensitized state. People with other chronic pain conditions, such as osteoarthritis or rheumatoid arthritis, have higher rates of fibromyalgia, which fits the idea that ongoing peripheral pain input can drive central sensitization over time. The teacher recalled that her pain began during a year when she was caring for her dying father while working full time and sleeping poorly, a period of stress and sleep loss that fits this pattern.
Why Treatments Work or Fail
The mechanism predicts which treatments help. Aerobic exercise, started gradually, is one of the most effective interventions and is thought to strengthen descending inhibition and improve sleep. Cognitive behavioral therapy reduces the impact of pain by changing how the brain responds to it. Improving sleep can reduce pain amplification.
Medications that act on central mechanisms have the most evidence. Serotonin-norepinephrine reuptake inhibitors, such as duloxetine and milnacipran, and low-dose tricyclic antidepressants, such as amitriptyline, increase descending inhibition by raising serotonin and norepinephrine in spinal pathways. Gabapentinoids such as pregabalin reduce the release of excitatory neurotransmitters, including glutamate and substance P, by binding to the alpha-2-delta subunit of voltage-gated calcium channels (Clauw, 2014).
The mechanism also predicts failures. Nonsteroidal anti-inflammatory drugs help little because the pain is not driven by inflammation. Opioids are generally ineffective and can worsen pain through opioid-induced hyperalgesia; people with fibromyalgia may already have high endogenous opioid activity, leaving little room for further benefit.
Explaining the Diagnosis to the Patient
The mechanism also shapes the conversation. Many patients with fibromyalgia have been told that nothing is wrong or that the pain is in their heads. Explaining central sensitization, that the nervous system's volume control has been turned up and that treatment aims to turn it down, validates the pain as real while explaining why tests are normal. The teacher said this was the first explanation that made sense to her, and she agreed to begin a walking program and a trial of duloxetine.
Conclusion
Fibromyalgia is pain without tissue damage, explained by central sensitization: increased excitability of spinal and brain pain pathways, elevated excitatory neurotransmitters and weakened descending inhibition, reinforced by poor sleep and stress. In this 44-year-old teacher, the mechanism explains her widespread pain, tenderness, fatigue, sleep disturbance and cognitive symptoms, her normal tests and the diagnostic criteria she met. It also predicts that exercise, sleep-focused care and centrally acting medications will help, while anti-inflammatory drugs and opioids will not.
References
Clauw, D. J. (2014). Fibromyalgia: A clinical review. JAMA, 311(15), 1547-1555. https://doi.org/10.1001/jama.2014.3266
Wolfe, F., Clauw, D. J., Fitzcharles, M.-A., Goldenberg, D. L., Hauser, W., Katz, R. L., Mease, P. J., Russell, A. S., Russell, I. J., & Walitt, B. (2016). 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Seminars in Arthritis and Rheumatism, 46(3), 319-329. https://doi.org/10.1016/j.semarthrit.2016.08.012
Woolf, C. J. (2011). Central sensitization: Implications for the diagnosis and treatment of pain. Pain, 152(3 Suppl.), S2-S15. https://doi.org/10.1016/j.pain.2010.09.030
How this NSG 521 Week 6 example is structured
The University of Phoenix library guide for NSG/521 lists Week 6 as Musculoskeletal, Neurologic, Psychiatric and Pain. The paper starts from the puzzle the patient presents, severe pain with no tissue damage, because explaining that puzzle is the purpose of the pathophysiology. It contrasts normal pain processing with central sensitization, maps the mechanism to her symptoms and to the diagnostic criteria, and ends with treatment, where the mechanism predicts both successes and failures. Students search this week as NSG 521 Week 6, NSG521 Wk 6 or NSG/521 Wk 6; all three are the same assignment.
NSG/521 Week 6 questions, answered
What does NSG/521 Week 6 usually ask for?
The library guide for NSG/521 lists Week 6 as musculoskeletal, neurologic, psychiatric and pain, with topics including arthritis, multiple sclerosis, osteoporosis, Parkinson disease, Alzheimer disease and mood disorders. Many sections ask for a paper on the pathophysiology of one condition applied to a patient.
Is fibromyalgia a real disease if tests are normal?
Yes. Normal tests show that there is no inflammation or tissue damage, but research shows measurable changes in how the nervous system processes pain. The pain is real; its source is amplification in the central nervous system rather than injury in the tissues.
Why don't opioids work well for fibromyalgia?
Opioids act mainly on pathways that respond to tissue injury, and people with fibromyalgia may already have high levels of endogenous opioid activity. Opioids can also cause hyperalgesia with long-term use. Treatments that restore descending inhibition, improve sleep and increase activity work better.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official University of Phoenix document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.